UK Companies House feature
VANTIVE LIMITED
Profile
- Company number
- 14981842
- Status
- Active
- Incorporation
- 2023-07-05
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After reviewing the Company's forecasts and projections, taking account of a severe but plausible change in trading performance, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The Company is secured to continue its operating activities with financial support from the parent company if required and through its cash pooling arrangement with the Group. The Company therefore continues to adopt the going concern basis in preparing its financial statements.”
Subsidiaries
- Vantive Limited Liability Company · 99.8% held · Greece · Trading
Significant events
- “On 31 January 2025, Baxter Healthcare Holding Limited, a company incorporated in Malta, sold its 100% interests in Vantive Health GmbH, 48% interest of Vantive Holding Limited and 100% interests in Vantive Holding B.V., a company incorporated in Netherlands, who indirectly owns the Company thru Vantive UK LLC, to Spruce Bid Co I Limited, a company incorporated in Ireland, in exchange for $1,423,187K cash.”
- “On 1 February 2025, Vantive, formerly the Baxter Kidney Care segment, was launched as a new standalone vital organ therapy company following the completion of its acquisition by CP Spuce Holdings, S.C.Sp., funds managed by global investment firm Carlyle, from BII.”
- “After the Global separation, the Company's ultimate parent company has changed to Vantive Limited (formerly Spruce TopCo Limited), a company registered in Jersey.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOA, Cassandra | Director | 2024-10-10 | Aug 1989 | Irish |
| WARBURTON, Andrew John | Director | 2023-08-31 | Sep 1974 | British |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FITZGERALD, Nicola Maria | Director | 2024-04-26 | 2024-09-27 |
| O'NEILL, Gerard Patrick | Director | 2023-07-05 | 2023-08-31 |
| SMIALEK, Michal Maciej | Director | 2023-07-05 | 2024-04-26 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| The Carlyle Group, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-01-31 | Active |
| Baxter International Incorporated | Corporate entity | Shares 75–100% | 2024-12-08 | Ceased 2025-01-31 |
| Baxter Healthcare Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-07-05 | Ceased 2024-12-08 |
Filing timeline
Last 20 of 22 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-07-30 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-07-23 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-07-10 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-06-26 | AA | accounts | accounts with accounts type full |
| 2025-06-23 | RESOLUTIONS | resolution | resolution |
| 2025-06-20 | MA | incorporation | memorandum articles |
| 2025-06-13 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-01-14 | SH01 | capital | capital allotment shares |
| 2025-01-08 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-01-08 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-10-14 | TM01 | officers | termination director company with name termination date |
| 2024-10-14 | AP01 | officers | appoint person director company with name date |
| 2024-07-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-04-29 | TM01 | officers | termination director company with name termination date |
| 2024-04-29 | AP01 | officers | appoint person director company with name date |
| 2023-09-21 | AD01 | address | change registered office address company with date old address new address |
| 2023-09-21 | AD01 | address | change registered office address company with date old address new address |
| 2023-09-06 | TM01 | officers | termination director company with name termination date |
| 2023-09-06 | AP01 | officers | appoint person director company with name date |
| 2023-09-01 | CERTNM | change-of-name | certificate change of name company |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Composite activity score · components 0–100 · reference 2026-05-10
34.6
COLD
/ 100
- Filings velocity 58
- Capital events 20
- Officer churn 0
- Headcount trajectory 50
- Accounts trajectory 50
- 7 filing(s) in last 12 months
- 1 capital event(s) in last 24 months